Top Markets
#1 GEKKO GEKKO +51.79%
#2 ADO Protocol ADO Protocol +38.56%
#3 Pons Pons +32.20%
#4 Helium Helium +28.69%
#5 TENDIES TENDIES +21.80%
#6 Giggle Fund Giggle Fund +20.11%
#7 OpenGradient OpenGradient +19.68%
#8 Prom Prom +18.47%
#9 龙虾 (Lobster) 龙虾 (Lobster) +17.88%
#10 Main Street Yield Main Street Yield +17.48%
Coin of the day
GEKKO GEKKO
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Classifica tra le azioni #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Prezzo delle azioni
$9.60
Ultima sincronizzazione: 2025-05-21
Capitalizzazione di mercato
$1.08B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
US
Scambia OptiNose, Inc. (OPTN)

Categoria

Healthcare
Numero di azioni in circolazione per OptiNose, Inc. (OPTN)
Numero di azioni in circolazione al March 2025: 11.67M
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di OptiNose, Inc., il numero attuale di azioni in circolazione è 11.67M. Alla fine del December 2023, la società aveva 112.08M azioni in circolazione. Il numero di azioni in circolazione è solitamente influenzato da split azionari e riacquisti.
Storico delle azioni in circolazione di OptiNose, Inc. (OPTN) dal 2015 al 2026
Azioni in circolazione alla fine di ogni anno
Anno Azioni in circolazione Cambia
2026 (TTM) 11.67M 14.88%
2024 10.16M -90.94%
2023 112.08M 1,857.16%
2022 5.73M -89.93%
2021 56.85M 17.77%
2020 48.28M 15.28%
2019 41.88M 5.31%
2018 39.77M 18.80%
2017 33.47M 1,131.11%
2016 2.72M -89.82%
2015 26.72M 0.00%
Azioni in circolazione per aziende simili o concorrenti
Azienda Azioni in circolazione Differenza Il paese
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 2.40B 20,463.38%
IN